Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens

doi:10.1186/1750-9378-3-9

Download references

Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens

Colomba Giorgi^*, Paola Di Bonito, Felicia Grasso, Stefania Mochi, Luisa Accardi, Maria G Donà, Margherita Branca, Silvano Costa, Luciano Mariani, Alberto Agarossi, Marco Ciotti, Kari Syrjänen and the HPV-PathogenISS group.

* Corresponding author: Colomba Giorgi colomba.giorgi@iss.it

Infectious Agents and Cancer 2008, 3:9 doi:10.1186/1750-9378-3-9

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

Infectious Agents and Cancer

Viewing options

Associated material

Tools

Share this article

Download references

Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens

Infectious Agents and Cancer

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Download references

Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens